US 12,466,810 B2
N-(5-(6-ethoxypyrazin-2-yl)pyridin-2-yl)-4-(2-(methylsulfonamido)pyrimidin-4-yl) tetrahydro-2H-pyran-4-carboxamide derivatives and related compounds as human CTPS1 inhibitors for the treatment of proliferative diseases
Abdul Quddus, Nottingham (GB); Andrew Novak, Nottingham (GB); David Cousin, Nottingham (GB); Emma Blackham, Nottingham (GB); Geraint Jones, Nottingham (GB); Joseph Wrigglesworth, Nottingham (GB); Lorna Duffy, Nottingham (GB); Louise Birch, Nottingham (GB); Pascal George, Paris (FR); and Saleh Ahmed, Nottingham (GB)
Assigned to Step Pharma S.A.S., Paris (FR)
Appl. No. 17/615,873
Filed by Step Pharma S.A.S., Paris (FR)
PCT Filed Jun. 4, 2020, PCT No. PCT/IB2020/000559
§ 371(c)(1), (2) Date Dec. 2, 2021,
PCT Pub. No. WO2020/245664, PCT Pub. Date Dec. 10, 2020.
Claims priority of application No. 19305713 (EP), filed on Jun. 4, 2019; and application No. 19306144 (EP), filed on Sep. 20, 2019.
Prior Publication US 2022/0324837 A1, Oct. 13, 2022
Int. Cl. C07D 401/14 (2006.01); C07D 239/38 (2006.01); C07D 239/42 (2006.01); C07D 401/04 (2006.01); C07D 405/04 (2006.01); C07D 405/14 (2006.01); C07D 409/14 (2006.01)
CPC C07D 401/14 (2013.01) [C07D 239/38 (2013.01); C07D 239/42 (2013.01); C07D 401/04 (2013.01); C07D 405/04 (2013.01); C07D 405/14 (2013.01); C07D 409/14 (2013.01)] 5 Claims
 
1. A compound which is N-(5-(6-ethoxypyrazin-2-yl) pyridin-2-yl)-4-(2-(ethylsulfonamido)pyrimidin-4-yl)tetrahydro-2H-pyran-4-carboxamide:

OG Complex Work Unit Chemistry
or a salt and/or solvate thereof.